Anticonvulsant effects of Setaria megaphylla root extract in mice.
Journal name: World Journal of Pharmaceutical Research
Original article title: Anticonvulsant effects of the ethanol root extract of setaria megaphylla (steud) t. dur and schinz in mice.
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
John A. Udobang, Jude E. Okokon and Ette O. Ettebong
Download the PDF file of the original publication
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Anticonvulsant effects of the ethanol root extract of setaria megaphylla (steud) t. dur and schinz in mice.
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr20178-9059
Copyright (license): WJPR: All rights reserved
Summary of article contents:
Introduction
The study investigates the anticonvulsant effects of the ethanol root extract of Setaria megaphylla (Steud) T. Dur and Schinz, a medicinal plant predominantly found in South-South Nigeria. Traditionally, this plant is utilized for treating various ailments such as malaria, hemorrhoids, and convulsions. Despite the utilization of its leaves in some studies, there has been minimal research focusing on its roots. This research aims to validate the ethnomedicinal claims regarding the usefulness of Setaria megaphylla roots in the treatment of seizures and epilepsy.
Anticonvulsant Effects of the Root Extract
The research demonstrated that administering the ethanol root extract at doses of 150, 300, and 450 mg/kg significantly delayed the onset of clonic and tonic convulsions induced by both aminophylline and pentylenetetrazole (PTZ). Notably, the highest dose of the extract exhibited a more profound effect than the standard drug diazepam, particularly in the PTZ-induced convulsions. Furthermore, the extract also significantly prolonged the time until death compared to the standard treatment. These results suggest a strong anticonvulsant effect attributable to the phytochemical components of the root extract.
Methodology of the Study
Adult Swiss albino mice were used for the experiments, which involved testing the anticonvulsant activity of the root extract. The root samples were collected and processed using a 70% ethanol extraction method. The research also included a qualitative phytochemical screening to identify key constituents in the extract, such as saponins, alkaloids, and flavonoids. The anticonvulsant activity was evaluated using both PTZ and aminophylline-induced convulsion models, with assessments made on the latency periods for convulsions and time to death.
Phytochemical Components and Mechanism of Action
The extract of Setaria megaphylla was found to contain several monoterpenes, such as terpinen-4-ol and α-terpineol, which have shown anticonvulsant activity in other studies. It is suggested that the anticonvulsant effect may stem from various mechanisms, including modulation of GABAergic transmission and inhibition of excitatory pathways. The observed efficacy of the extract could be due to its capability to enhance GABA-mediated inhibitory functions within the brain, thereby influencing seizure activity.
Conclusion
The findings of this study support the traditional use of Setaria megaphylla roots in managing convulsions and epilepsy. The demonstrated anticonvulsant properties of the ethanol root extract highlight the potential for further exploration of its pharmacological effects, specifically in identifying and isolating the active components responsible for these properties. The confirmation of its effectiveness endorses the need for more comprehensive studies to standardize its application in herbal medicine.
FAQ section (important questions/answers):
What medicinal uses are associated with Setaria megaphylla?
Setaria megaphylla is traditionally used to treat malaria, inflammation, diabetes, hemorrhoids, and convulsions among other ailments in South-South Nigeria.
How was the anticonvulsant effect of the root extract tested?
The root extract was tested against aminophylline and pentylenetetrazole-induced convulsions in mice using doses of 150, 300, and 450 mg/kg to evaluate effectiveness.
What significant results were observed from the study?
The study found that the root extract significantly delayed the onset of convulsions and prolonged the time of death compared to the control group, showing potential anticonvulsant effects.
What are some of the phytochemical constituents in Setaria megaphylla?
The extract contains saponins, alkaloids, tannins, flavonoids, terpenes, and cardiac glycosides, which may contribute to its potential medicinal effects.
What was the method of extraction for the root sample?
The roots were macerated in 70% ethanol for 72 hours, then concentrated and evaporated to isolate the extract for testing.
How does the study validate traditional medicinal usage of the plant?
The significant anticonvulsant effects observed in experimental models support ethnomedicinal claims that suggest its use in treating convulsions and epilepsy.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Anticonvulsant effects of Setaria megaphylla root extract in mice.”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Drug:
The term 'Drug' refers to any substance that produces a physiological effect when introduced into the body. In the context of this study, the ethanol root extract from Setaria megaphylla is investigated for its potential pharmacological properties, specifically its anticonvulsant effects against induced seizures in mice, analogous to standard anticonvulsant medications like diazepam.
2) Death:
In the study, 'Death' relates to the mortality outcomes observed in mice following convulsive events induced by aminophylline and pentylenetetrazole. The timing and incidence of death serve as critical endpoints for evaluating the efficacy of the Setaria megaphylla extract against convulsions, highlighting the extract's protective qualities.
3) Activity:
'Activity' refers to the pharmacological effects exerted by the Setaria megaphylla root extract on seizures. The evaluation of anticonvulsant activity in this study is crucial for understanding how various doses of the extract influence the onset and severity of seizures, revealing its potential therapeutic implications.
4) Animal:
The term 'Animal' signifies the use of living organisms, specifically adult Swiss albino mice in this study, to evaluate the pharmacological effects of the ethanolic extract. Animals are essential in preclinical trials, providing insights into the metabolic and physiological responses to new potential treatments before human studies.
5) Table:
'Table' indicates the organized data representation of experimental results. In this study, tables summarize critical outcomes relating to the latency of convulsions and mortality rates under different treatment conditions, aiding in the visual comparison of results and facilitating the analysis of the extracted data.
6) Phytochemical:
'Phytochemical' pertains to the bioactive compounds derived from plants that can exhibit various health benefits. In this research, phytochemical screening of the Setaria megaphylla extract is conducted to identify specific constituents—such as flavonoids and tannins—that may contribute to its anticonvulsant properties.
7) Pharmacology:
'Pharmacology' is the branch of science that studies the interactions between drugs and biological systems. This research falls under pharmacology, as it investigates the therapeutic effects of the Setaria megaphylla extract on seizures, providing evidence for its potential medicinal application.
8) Epilepsy:
'Epilepsy' refers to a neurological disorder characterized by recurrent seizures. The study aims to explore the anticonvulsant effects of the Setaria megaphylla extract, thus contributing to the scientific understanding of treatments for epilepsy, an important condition with significant global prevalence.
9) Study (Studying):
The word 'Study' highlights the systematic investigation conducted to explore the anticonvulsant effects of Setaria megaphylla. It encompasses the methodology, results, and conclusions drawn from the research, emphasizing its role in expanding knowledge regarding potential treatments for seizure disorders.
10) Toxicology:
'Toxicology' involves the study of the adverse effects and safety of substances on living organisms. In this research, toxicological assessments determine the safety profile of the Setaria megaphylla extract, informing the appropriate dosing and potential hazards associated with its use in vivo.
11) Toxicity:
'Toxicity' relates to the degree to which a substance can cause harm to an organism. This study includes the evaluation of the extract's toxicity, ensuring that effective doses do not pose serious health risks, thus supporting its potential therapeutic application without compromising safety.
12) Science (Scientific):
'Science' is a systematic pursuit of knowledge through observation, experimentation, and analysis. The research exemplifies scientific inquiry, employing controlled experiments to assess the pharmacological properties of a natural product, contributing to the broader understanding of traditional medicine and drug discovery.
13) Powder:
'Powder' refers to the form of the root extract used in this investigation. The powdered form results from the drying and grinding process, facilitating the extraction of phytochemicals and ensuring proper dosing for biological testing, an essential step in evaluating its medicinal properties.
14) House:
'House' in this context refers to the 'Animal House' facility where the Swiss albino mice were kept for the study. Maintaining animals in a controlled environment is crucial for ensuring consistent conditions, contributing to the reproducibility of experimental results and the welfare of the animals.
15) Inflammation:
'Inflammation' describes the biological response to harmful stimuli, often associated with pain and other symptoms. Though the study primarily focuses on anticonvulsant effects, understanding related conditions such as inflammation helps contextualize the broader therapeutic potential of medicinal plants like Setaria megaphylla.
16) Neurasthenia:
'Neurasthenia' refers to a condition characterized by fatigue, anxiety, and depression. This research indirectly relates to neurasthenia by exploring how the plant's traditional use for psychological disorders may stem from its broader neuroprotective properties, linking emotional health and seizure management.
17) Discussion:
'Discussion' indicates the part of the research where findings are interpreted and contextualized. In this study, the discussion section provides insights into the implications of the results, linking them to existing literature and suggesting avenues for future research on Setaria megaphylla’s therapeutic uses.
18) Suffering:
'Suffering' highlights the experiences of patients with conditions such as epilepsy or convulsive disorders. This study addresses the need for effective therapeutic options, underscoring the relevance of traditional medicinal plants in alleviating suffering and enhancing the quality of life for affected individuals.
19) Psychosis:
'Psychosis' encompasses mental health disorders characterized by a disconnection from reality, often linked to stress and psychological distress. The traditional applications of Setaria megaphylla may include treatments for psychosis, illustrating the plant's potential versatility in addressing various psychological conditions.
20) Flavonoid:
'Flavonoid' refers to a group of plant compounds known for their antioxidant and anti-inflammatory properties. The study investigates phytochemicals like flavonoids present in the Setaria megaphylla extract, hypothesizing their role in mediating anticonvulsant activity and enhancing the extract’s therapeutic profile.
21) Pregnant:
'Pregnant' refers to the state of carrying a developing fetus. The use of traditional remedies during pregnancy raises safety considerations, and exploration into Setaria megaphylla’s medicinal properties includes its historical applications, ensuring that potential risks or benefits are considered in maternal health contexts.
22) Debility:
'Debility' refers to physical weakness or lack of strength, often resulting from illness. The study's exploration of Setaria megaphylla's potential therapeutic effects aligns with the need for effective remedies for debility, particularly for those suffering from conditions leading to weakened health and vitality.
23) Species:
'Species' indicates the biological classification pertinent to the plant studied. Setaria megaphylla is investigated for its unique properties within the Poaceae family, emphasizing the importance of species-specific attributes in the pharmacological evaluation within the field of ethnobotany and natural product research.
24) Forest:
'Forest' signifies the natural habitat where Setaria megaphylla was collected. The ecological context of medicinal plants is crucial for understanding their availability and the traditional knowledge surrounding their use, linking biodiversity conservation with sustainable medicinal practices and community health benefits.
25) Botany:
'Botany' is the scientific study of plants, encompassing their physiology, structure, and taxonomy. The identification and authentication of Setaria megaphylla in the study involve botanical expertise, illustrating the importance of botany in discovering and validating the therapeutic applications of plants.
26) India:
'India' represents one geographical area where Setaria megaphylla is found, underlining the plant's global distribution and cultural significance. Its mention connects the research to the broader traditional practices and botanical knowledge in various regions, enhancing the understanding of its ethnomedicinal relevance.
27) Water:
'Water' is essential for the plant's growth and often influences the efficacy of extracts. The mention of water pertains to the habitat of Setaria megaphylla, highlighting environmental factors affecting its medicinal properties and the physiological responses observed in biological experiments.
28) Ivory:
'Ivory' relates to the Ivory Coast, where traditional uses of Setaria megaphylla for treating convulsions are documented. This geographical reference signifies the cultural and historical context of medicinal plant usage, emphasizing the importance of regional practices in the understanding of ethnomedicine.
29) Fever:
'Fever' is a common symptom often associated with various diseases. Setaria megaphylla’s traditional use in treating fever, along with convulsions, indicates its potential multi-faceted pharmacological applications, showcasing the need for further research into its efficacy in managing common health conditions.
30) Hind:
'Hind' refers to the posterior part or back. In the context of this study, it might relate to observations regarding convulsion manifestations or potential side effects following treatment, emphasizing the comprehensive understanding of drug effects and their implications for animal welfare and therapeutic outcomes.
31) Sign:
'Sign' indicates observable effects or indicators of a condition. In this research, signs of convulsions, including latency and severity, are measured as essential criteria to assess the effectiveness of the Setaria megaphylla extract, illustrating the importance of key indicators in pharmacological evaluations.
32) Pain:
'Pain' reflects the associated discomfort or distress experienced during convulsions or related ailments. The potential analgesic properties of Setaria megaphylla imply its broader therapeutic implications for pain management, thus extending the scope of research into its medicinal value beyond anticonvulsant effects.
Other Science Concepts:
Discover the significance of concepts within the article: ‘Anticonvulsant effects of Setaria megaphylla root extract in mice.’. Further sources in the context of Science might help you critically compare this page with similair documents:
Setaria megaphylla, Herbarium specimen, Acute toxicity study, Dose-dependent, Standard procedure, Standard drug diazepam, Clinical pharmacology, Anticonvulsant effect, Qualitative phytochemical screening, Toxicity signs, Active component, Ethnomedicinal claim, Pentylenetetrazole-induced convulsion, Ethanol root extract, Tonic convulsions, Significant delay, Animal stock, Clonic convulsion, Phytochemical component.